Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

• Principais autores: Tianmei Zeng (Autor), Lili Zhou (Autor), Hao Xi (Autor), Weijun Fu (Autor), Juan Du (Autor), Chunyang Zhang (Autor), Hua Jiang (Autor), Jian Hou (Autor)
• Formato: Livro
• Publicado em: Hindawi Limited, 2015-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Aim. To evaluate whether patients with multiple myeloma at various risks can still benefit the same from autologous stem cell transplantation consolidation in the era of novel agents. We retrospectively analyzed 67 consecutive myeloma patients receiving autologous stem cell transplantation after bor...